Two German companies, Mahle GmbH and Schott Pharma AG, are exploring initial public offerings of their Indian businesses that could raise as much as $400 million each, according to people familiar with the matter, as multinational firms seek to tap the premium valuations commanded by their locally listed peers.
Mostramos publicamente o ponto principal. Crie uma conta gratuita para continuar lendo o artigo completo, salva-lo, comenta-lo e conecta-lo ao contexto de mercado e OSINT.